ASMB
ASMB
NASDAQ · Biotechnology

Assembly Biosciences Inc

$24.97
-0.37 (-1.46%)
As of Sep 20, 10:28 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target -56.3% upside
Low Target $9.01
Average Target $10.92
High Target $17.95
Current Price $24.97
Current
$24.97
Target
$10.92
$9.01 $10.92 avg $17.95
Scenario Analysis
Bear Case
$9.01
-63.9%
Low target
Base Case
$10.92
-56.3%
Avg target
Bull Case
$17.95
+-28.1%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$39.71
-37.1% from high
52-Week Low
$20.23
+23.4% from low
Target vs 52W High
$10.92
-72.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%